Cited by 74Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentPharmacovigilance and Adverse Drug Reactions

An update on zolpidem abuse and dependence

Victorri-Vigneau, Caroline, Gérardin, Marie, Rousselet, Morgane, Guerlais, Marylène, Grall-Bronnec, Marie, Jolliet, Pascale·2014·Journal of Addictive Diseases

Abstract

In 2004, the health authorities (French National Agency for Medicines and Health Products Safety-ANSM) modified the summary of zolpidem characteristics. Particularly it now includes the sentence "a pharmacodependence may materialize." The current article aims to show that despite this modification, zolpidem continues to be associated with problematic drug use, as the official system (Center for Evaluation and Information on Pharmacodependence-Addictovigilance network) providing information on the abuse and dependence potential of drugs informs us. The authors reviewed the literature on this topic and analyzed French data from zolpidem's postmarketing period that were collected by the Addictovigilance network from 2003 to 2010. Postmarketing data and the 30 case reports yielded from the literature review highlight a significant dependence and abuse potential for zolpidem. This survey led to propose in stronger additional rules in France to try to mitigate the abuse potential of zolpidem.

Integrity signals

Registry

Crossref · 10.1080/10550887.2014.882725

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Victorri-Vigneau, C., Gérardin, M., Rousselet, M., Guerlais, M., Grall-Bronnec, M., & Jolliet, P.
Affiliations
Centre Hospitalier Universitaire de Nantes (FR)
Venue
Journal of Addictive Diseases
Published
2014-01
Volume
33
Issue
1
Pages
15-23
ISSN
  • 1055-0887 (ISSN-L)
  • 1545-0848
OpenAlex
W2041130859
Cited by
74
References
34
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 8 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 2 · 2016: 7 · 2015: 7
FWCI
4.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Addictive Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
zolpidem, drug addiction, drug abuse, hypnotic misuse, pharmacodependence, post-marketing surveillance, regulatory risk assessment, benzodiazepine-like drugs, France
MeSH terms
Zolpidem, Adult, Aged, Female, France, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Product Surveillance, Postmarketing, Pyridines, Mandatory Reporting, Substance-Related Disorders, Young Adult, Prescription Drug Misuse, Prescription Drug Diversion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review